tirzepatide journal club The story behind Ozempic -

No single peptide dominates the literature research is split across four categories by mechanism: incretin-pathway compounds like GLP-3 RT, fragment-based lipolytic peptides like AOD-9604, growth-hormone-releasing analogs like Tesamorelin, and secretagogue pairings like CJC-1295/Ipamorelin

Long-term risk of a fatty liver in liver donors

This graphic highlights a major shift: brand and specialty drugs are facing accelerating pressure from generics, biosimilars, and evolving payer dynamics

doi: 10.2147/DMSO.S312527 16 FarkasESzilvsy-SzabARuskaYSinkRRaschMGEgebjergTet al

The drugs side effects are expected to be similar when used off-label for weight loss